Asra Minerals Ltd
ASX:ASR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Asra Minerals Ltd
ASX:ASR
|
AU |
|
Diaceutics PLC
LSE:DXRX
|
UK |
|
H
|
Hefei Chipmore Technology Co Ltd
SSE:688352
|
CN |
|
S
|
SKF India Ltd
BSE:500472
|
IN |
|
V
|
Vrain Solution Inc
TSE:135A
|
JP |
|
Intergis Co Ltd
KRX:129260
|
KR |
|
EpiCentre Holdings Ltd
SGX:5MQ
|
SG |
|
I
|
Ikab Securities and Investment Ltd
BSE:514238
|
IN |
|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
JP |
|
N
|
Novo Resources Corp
SWB:1NO
|
CA |
|
P
|
PXP Energy Corp
XPHS:PXP
|
PH |
Cash Flow Statement
Cash Flow Statement
Asra Minerals Ltd
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Stock-Based Compensation |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Change in Working Capital |
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Cash from Operating Activities |
(1)
N/A
|
(2)
-63%
|
(3)
-38%
|
(2)
+9%
|
(2)
+32%
|
(2)
-13%
|
(2)
-7%
|
(2)
+25%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(6)
|
(6)
|
(5)
|
(4)
|
(2)
|
(2)
|
(3)
|
(3)
|
|
| Other Items |
0
|
(2)
|
(2)
|
0
|
(0)
|
0
|
1
|
1
|
|
| Cash from Investing Activities |
(6)
N/A
|
(8)
-51%
|
(8)
+11%
|
(4)
+49%
|
(2)
+58%
|
(2)
-46%
|
(2)
+32%
|
(2)
-33%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
8
|
8
|
9
|
7
|
2
|
1
|
3
|
2
|
|
| Net Issuance of Debt |
1
|
0
|
0
|
2
|
2
|
0
|
(2)
|
(2)
|
|
| Other |
0
|
2
|
1
|
(3)
|
(2)
|
3
|
0
|
1
|
|
| Cash from Financing Activities |
8
N/A
|
10
+20%
|
9
-6%
|
7
-24%
|
3
-53%
|
5
+37%
|
5
+1%
|
1
-81%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
1
N/A
|
(1)
N/A
|
(1)
-87%
|
1
N/A
|
0
-96%
|
0
+938%
|
1
+248%
|
(3)
N/A
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(7)
N/A
|
(8)
-18%
|
(8)
-1%
|
(7)
+17%
|
(3)
+52%
|
(4)
-32%
|
(5)
-7%
|
(5)
-7%
|
|